Titan Medical Inc (TMDIF)

[Bristol19]

Good points.
Software tweaking for medical device development, especially for something as critical as hand-to-effector control, is very costly in terms of time and money. The primary reason for that is documentation control/management, testing (which needs to always be extensive), and compliance. All these are regulated and scrutinized in the approval process. I'm glad that Ximedica would be dealing with this.
However, Titan needs to make sure it has the bucks to pay for what additional tweaking is done, especially in late stages. Assuming a constant burn rate is not realistic.